1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Structural heart defects

Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy TSID 12015

Awaiting development [GID-TA11551] Expected publication date: TBC

  • Project information
  • Project documents

28555-Eplontersen-for-Familial-Amyloid-Polyneuropathy-V1.0-JUL2023-NON-CONF.pdf (nihr.ac.uk)